Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

How to predict the market trend for the New Year? How to strategize for opportunities next year? The strategies from the top ten securities firms are here.

Hong Kong-listed company 18C Corporation is making waves in the Physical AI sector by holding a hearing on May 1st.

FENBI (02469) partners with Huatu strategically to reshape the valuation logic of top-level collaboration in vocational education.
How to predict the market trend for the New Year? How to strategize for opportunities next year? The strategies from the top ten securities firms are here.

Hong Kong-listed company 18C Corporation is making waves in the Physical AI sector by holding a hearing on May 1st.

FENBI (02469) partners with Huatu strategically to reshape the valuation logic of top-level collaboration in vocational education.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


